{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T11:03:56Z","timestamp":1753182236293,"version":"3.41.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The aim of the study was to evaluate the clinical utility of pretreatment <jats:sup>18<\/jats:sup>F-FDG PET\/CT with quantitative evaluation of peritoneal metabolic cartography in relation to staging laparoscopy for ovarian carcinomatosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods<\/jats:title>\n            <jats:p>A retrospective review of prospectively collected data from 84 patients with FIGO (International Federation of Gynecology and Obstetrics) stage IIIC to IV ovarian cancer was carried out. All patients had a double-blinded <jats:sup>18<\/jats:sup>F-FDG PET\/CT review. Discriminant capacity of metabolic parameters to identify peritoneal carcinomatosis in the 13 abdominal regions according to the peritoneal cancer index was estimated with area under the receiver operating characteristic curve (AUC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The metabolic parameter showing the best trade-off between sensitivity and specificity to predict peritoneal extension compared with peritoneal cancer index score was the metabolic tumor volume (MTV), with a Spearman \u03c1 equal to 0.380 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). The AUC of MTV to diagnose peritoneal involvement in the upper abdomen (regions 1, 2, and 3) ranged from 0.740 to 0.765. MTV AUC values were lower in the small bowel regions (9\u201312), ranging from 0.591 to 0.681, and decreased to 0.487 in the pelvic region 6. <jats:sup>18<\/jats:sup>F-FDG PET\/CT also improved the detection of extra-abdominal disease, upstaging 35 patients (41.6%) from stage IIIC to IV compared with CT alone and leading to treatment modification in more than one third of patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>\n                                 <jats:sup>18<\/jats:sup>F-FDG PET\/CT metrics are highly accurate to reflect peritoneal tumor burden, with variable diagnostic value depending on the anatomic region. MTV is the most representative metabolic parameter to assess peritoneal tumor extension.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000003785","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T05:10:13Z","timestamp":1625807413000},"page":"797-806","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Performance of Multiparametric Functional Imaging to Assess Peritoneal Tumor Burden in Ovarian Cancer"],"prefix":"10.1097","volume":"46","author":[{"given":"Estelle","family":"Mallet","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology, Centre Antoine Lacassagne, Nice"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina Aida","family":"Angeles","sequence":"additional","affiliation":[{"name":"Surgical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bastien","family":"Cabarrou","sequence":"additional","affiliation":[{"name":"Biostatistics, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Chardin","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Centre Antoine Lacassagne"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Viau","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Centre Hospitalier Universitaire de Nice"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Frigenza","sequence":"additional","affiliation":[{"name":"Department of Gynecological Surgery, Centre Hospitalier Universitaire de Nice, Nice"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Sophie","family":"Navarro","sequence":"additional","affiliation":[{"name":"Surgical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Ducassou","sequence":"additional","affiliation":[{"name":"Radiotherapy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Betrian","sequence":"additional","affiliation":[{"name":"Medical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Mart\u00ednez-G\u00f3mez","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Centre Oscar Lambret, Lille"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Tanguy Le Gac","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elodie","family":"Chantalat","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Motton","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gw\u00e9na\u00ebl","family":"Ferron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuel","family":"Barranger","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Centre Antoine Lacassagne, Nice"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwan","family":"Gabiache","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,7,8]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7150\/jca.7810","article-title":"Current approaches and challenges in managing and monitoring treatment response in ovarian cancer","volume":"5","year":"2014","journal-title":"J Cancer"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/ijgc-2019-000308","article-title":"ESMO\u2013ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"29","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1158\/1078-0432.CCR-12-2243","article-title":"New strategies in the treatment of ovarian cancer: current clinical perspectives and future potential","volume":"19","year":"2013","journal-title":"Clin Cancer Res"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.3802\/jgo.2017.28.e48","article-title":"Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer","volume":"28","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1245\/s10434-015-5069-z","article-title":"Surgical complexity impact on survival after complete cytoreductive surgery for advanced ovarian cancer","volume":"23","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1148\/rg.233025105","article-title":"Multidetector CT of peritoneal carcinomatosis from ovarian cancer","volume":"23","year":"2003","journal-title":"RadioGraphics"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"e500","DOI":"10.5114\/pjr.2018.80247","article-title":"Computed tomography imaging of ovarian peritoneal carcinomatosis: a pictorial review","volume":"83","year":"2018","journal-title":"Pol J Radiol"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1200\/JCO.2016.69.2962","article-title":"Laparoscopy to predict the result of primary cytoreductive surgery in patients with advanced ovarian cancer: a randomized controlled trial","volume":"35","year":"2017","journal-title":"J Clin Oncol"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"462.e1","DOI":"10.1016\/j.ajog.2013.07.016","article-title":"A multicentric trial (Olympia-MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer","volume":"209","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.gofs.2019.01.003","article-title":"Chirurgie des cancers avanc\u00e9s de l\u2019ovaire. Article r\u00e9dig\u00e9 sur la base de la recommandation nationale de bonnes pratiques cliniques en canc\u00e9rologie intitul\u00e9e \u201cConduites \u00e0 tenir initiales devant des patientes atteintes d\u2019un cancer \u00e9pith\u00e9lial de l\u2019ovaire\u201d","volume":"47","year":"2019","journal-title":"Gyn\u00e9cologie Obs Fertil S\u00e9nologie"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/ijgc-2019-000308","article-title":"ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"29","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.ejogrb.2018.08.338","article-title":"Interval surgery in advanced stage ovarian cancer","volume":"234","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/IGC.0000000000001173","article-title":"Specific regions, rather than the entire peritoneal carcinosis index, are predictive of complete resection and survival in advanced epithelial ovarian cancer","volume":"28","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/RLU.0b013e31826390ec","article-title":"Peritoneal carcinomatosis in patients with ovarian cancer","volume":"38","year":"2013","journal-title":"Clin Nucl Med"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.3802\/jgo.2018.29.e98","article-title":"Performance of pre-treatment 18F-fluorodeoxyglucose positron emission tomography\/computed tomography for detecting metastasis in ovarian cancer: a systematic review and meta-analysis","volume":"29","year":"2018","journal-title":"J Gynecol Oncol"},{"key":"bib17-20250621","first-page":"22","article-title":"Role of 18F-FDG PET\/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker ca-125","volume":"33","year":"2014","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"20170519","DOI":"10.1259\/bjr.20170519","article-title":"Diagnostic accuracy of 18F-FDG PET\/CT for detection of peritoneal carcinomatosis; a systematic review and meta-analysis","volume":"91","year":"2018","journal-title":"Br J Radiol"},{"key":"bib19-20250621","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/RLU.0000000000000768","article-title":"Peritoneal carcinomatosis in primary ovarian cancer staging: comparison between MDCT, MRI, and 18F-FDG PET\/CT","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2012.04.023","article-title":"FDG PET\/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread","volume":"126","year":"2012","journal-title":"Gynecol Oncol"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2217\/WHE.11.91","article-title":"Impact of FDG-PET and -PET\/CT imaging in the clinical decision-making of ovarian carcinoma: an evidence-based approach","volume":"8","year":"2012","journal-title":"Womens Health (Lond)"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ygyno.2013.09.024","article-title":"Preoperative 18F-FDG PET\/CT in the management of advanced epithelial ovarian cancer","volume":"131","year":"2013","journal-title":"Gynecol Oncol"},{"key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1157\/13073787","article-title":"Meta-an\u00e1lisis de la eficacia diagn\u00f3stica de la PET-FDG en pacientes con sospecha de recurrencia por c\u00e1ncer de ovario","volume":"24","year":"2005","journal-title":"Rev Espa\u00f1ola Med Nucl"},{"key":"bib24-20250621","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","year":"1996","journal-title":"Cancer Treat Res"},{"key":"bib25-20250621","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib26-20250621","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","article-title":"What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?","volume":"103","year":"2006","journal-title":"Gynecol Oncol"},{"key":"bib27-20250621","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","year":"2002","journal-title":"J Clin Oncol"},{"key":"bib28-20250621","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/bjs.10527","article-title":"Evaluation of the peritoneal carcinomatosis index with CT and MRI","volume":"104","year":"2017","journal-title":"Br J Surg"},{"key":"bib29-20250621","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1471-2407-9-171","article-title":"Neoadjuvant chemotherapy or primary surgery for stage III\/IV ovarian cancer: contribution of diagnostic laparoscopy","volume":"9","year":"2009","journal-title":"BMC Cancer"},{"key":"bib30-20250621","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ygyno.2015.03.049","article-title":"Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: time to incorporate laparoscopic assessment into the standard of care","volume":"137","year":"2015","journal-title":"Gynecol Oncol"},{"key":"bib31-20250621","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/IGC.0b013e3182a616a7","article-title":"Accuracy and reproducibility of the peritoneal cancer index in advanced ovarian cancer during laparoscopy and laparotomy","volume":"23","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"bib32-20250621","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ygyno.2004.11.031","article-title":"Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study","volume":"96","year":"2005","journal-title":"Gynecol Oncol"},{"key":"bib34-20250621","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jviscsurg.2015.06.003","article-title":"Pitfalls and mimickers on (18)F-FDG-PET\/CT in peritoneal carcinomatosis from colorectal cancer: an analysis from 37 patients","volume":"152","year":"2015","journal-title":"J Visc Surg"},{"key":"bib35-20250621","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.ejrad.2016.08.006","article-title":"Use of (18)F-FDG PET\/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue","volume":"85","year":"2016","journal-title":"Eur J Radiol"},{"key":"bib36-20250621","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ygyno.2013.08.020","article-title":"PET\/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer","volume":"131","year":"2013","journal-title":"Gynecol Oncol"},{"key":"bib37-20250621","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1245\/s10434-009-0387-7","article-title":"18F-FDG-PET\/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"16","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"bib38-20250621","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2013.08.023","article-title":"A prospective comparison of integrated FDG-PET\/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer","volume":"131","year":"2013","journal-title":"Gynecol Oncol"},{"key":"bib39-20250621","first-page":"488","article-title":"Validation of diagnostic methods for peritoneal carcinomatosis secondary to ovarian cancer. CT-SCAN, PET-CT or laparoscopy, what is the best?","volume":"70","year":"2018","journal-title":"Minerva Ginecol"},{"key":"bib40-20250621","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2007.11.002","article-title":"Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography\/computed tomography\u2014a prospective study","volume":"108","year":"2008","journal-title":"Gynecol Oncol"},{"key":"bib41-20250621","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1016\/j.ejrad.2012.03.020","article-title":"Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET\/CT scans for diagnosing ovarian cancer recurrence","volume":"81","year":"2012","journal-title":"Eur J Radiol"},{"key":"bib42-20250621","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1245\/s10434-011-2153-x","article-title":"Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer","volume":"19","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"bib43-20250621","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12149-018-1289-1","article-title":"Prognostic value of volume-based metabolic parameters of 18F-FDG PET\/CT in ovarian cancer: a systematic review and meta-analysis","volume":"32","year":"2018","journal-title":"Ann Nucl Med"},{"key":"bib44-20250621","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejrad.2017.05.036","article-title":"F-18 FDG PET\/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer","volume":"93","year":"2017","journal-title":"Eur J Radiol"},{"key":"bib45-20250621","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1007\/s00330-015-3729-9","article-title":"Volume-based quantitative FDG PET\/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery","volume":"25","year":"2015","journal-title":"Eur Radiol"},{"key":"bib46-20250621","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.semnuclmed.2019.06.010","article-title":"PET\/CT for evaluation of ovarian cancer","volume":"49","year":"2019","journal-title":"Semin Nucl Med"},{"key":"bib47-20250621","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1186\/s12885-018-5067-1","article-title":"Prognostic significance of supradiaphragmatic lymph node metastasis detected by 18F-FDG PET\/CT in advanced epithelial ovarian cancer","volume":"18","year":"2018","journal-title":"BMC Cancer"},{"key":"bib48-20250621","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1157\/13071687","article-title":"Impacto de la tomograf\u00eda por emisi\u00f3n de positrones mediante 18-fluoro-2-desoxi-d-glucosa (PET-FDG) en el manejo terap\u00e9utico de pacientes con recurrencia secundaria a c\u00e1ncer de ovario","volume":"24","year":"2005","journal-title":"Rev Esp Med Nucl"},{"key":"bib49-20250621","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ygyno.2018.11.001","article-title":"Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer","volume":"152","year":"2019","journal-title":"Gynecol Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003785","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:02:16Z","timestamp":1750536136000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,8]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003785","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2021,7,8]]}}}